Distinctive proteomic profiles among different regions of human carotid plaques in men and women

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Liang, Wenzhao ^a,b   Ward, Liam J ^a   Karlsson, Helen ^a   Ljunggren, Stefan A ^a   Li, Wei ^a   Lindahl, Mats ^a   Yuan, Xi Ming ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOFERRITIN; PREALBUMIN; PROTEOME;

AGED; CAROTID ARTERY OBSTRUCTION; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MALE; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MIDDLE AGED; PATHOLOGY; PROTEOMICS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APOFERRITINS; CAROTID STENOSIS; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PREALBUMIN; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84969932826     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26231     Document Type: Article

References (42)

1. Ross, R. Atherosclerosis is an inflammatory disease. Am. Heart J. 138, S419-420 (1999).
2. Falk, E., Nakano, M., Bentzon, J. F., Finn, A. V. & Virmani, R. Update on acute coronary syndromes: The pathologists view. Eur. Heart J. 34, 719-728, doi: 10.1093/eurheartj/ehs411 (2013).
3. Box, L. C. et al. Heterogeneity of atherosclerotic plaque characteristics in human coronary artery disease: A three-dimensional intravascular ultrasound study. Catheter Cardiovasc. Interv. 70, 349-356, doi: 10.1002/ccd.21088 (2007).
4. Eberini, I. et al. A proteomic portrait of atherosclerosis. J. Proteomics 82C, 92-112, doi: 10.1016/j.jprot.2013.02.007 (2013).
5. Duran, M. C. et al. Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques. Eur. J. Pharmacol. 562, 119-129, doi: 10.1016/j.ejphar.2007.01.077 (2007).
6. Viiri, L. E. et al. Smooth muscle cells in human atherosclerosis: Proteomic profiling reveals differences in expression of Annexin A1 and mitochondrial proteins in carotid disease. J. Mol. Cell. Cardiol. 54, 65-72, doi: 10.1016/j.yjmcc.2012.11.002 (2012).
7. Olson, F. J. et al. Consistent differences in protein distribution along the longitudinal axis in symptomatic carotid atherosclerotic plaques. Biochem. Biophys. Res. Commun. 401, 574-580, doi: 10.1016/j.bbrc.2010.09.103 (2010).
8. Bagnato, C. et al. Proteomics analysis of human coronary atherosclerotic plaque: A feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol. Cell. Proteomics 6, 1088-1102, doi: 10.1074/mcp.M600259-MCP200 (2007).
9. Porcelli, B. et al. Proteomic analysis of atherosclerotic plaque. Biomed. Pharmacother. 64, 369-372, doi: 10.1016/j.biopha.2009.10.005 (2010).
10. Stary, H. et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92, 1355-1374, doi: 10.1161/01.CIR.92.5.1355 (1995).
11. Loppnow, H., Buerke, M., Werdan, K. & Rose-John, S. Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis. J. Cell. Mol. Med. 15, 484-500, doi: 10.1111/j.1582-4934.2010.01245.x (2011).
12. Riessen, R. et al. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am. J. Pathol. 144, 962-974 (1994).
13. OBrien, K. et al. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation 98, 519-527 (1998).
14. Barascuk, N. et al. Levels of circulating MMCN-151, a degradation product of mimecan, reflect pathological extracellular matrix remodelling in apolipoprotein E knockout mice. Biomarker Insights 6, 97-106 (2011).
15. Adair-Kirk, T. L. & Senior, R. M. Fragments of extracellular matrix as mediators of inflammation. Int. J. Biochem. Cell Biol. 40, 1101-1110, doi: 10.1016/j.biocel.2007.12.005 (2008).
16. Assinder, S. J., Stanton, J.-A. L. & Prasad, P. D. Transgelin: An actin-binding protein and tumour suppressor. Int. J. Biochem. Cell Biol. 41, 482-486, doi: 10.1016/j.biocel.2008.02.011 (2009).
17. Garcia-Arguinzonis, M., Padro, T., Lugano, R., Llorente-Cortes, V. & Badimon, L. Low-density lipoproteins induce heat shock protein 27 dephosphorylation, oligomerization, and subcellular relocalization in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 30, 1212-1219, doi: 10.1161/ATVBAHA.109.198440 (2010).
18. Nair, R., Solway, J. & Boyd, D. Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression. J. Biol. Chem. 281, 26424-26436 (2006).
19. Walsh, M. P. Vascular smooth muscle myosin light chain diphosphorylation: mechanism, function, and pathological implications. IUBMB life 63, 987-1000, doi: 10.1002/iub.527 (2011).
20. de la Cuesta, F. et al. A proteomic focus on the alterations occurring at the human atherosclerotic coronary intima. Mol. Cell. Proteomics 10, M110 003517, doi: 10.1074/mcp.M110.003517 (2011).
21. Hawiger, J. Mechanisms involved in platelet vessel wall interaction. Thromb. Haemost. 74, 369-372 (1995).
22. Lepedda, A. J. et al. A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis 203, 112-118, doi: 10.1016/j.atherosclerosis.2008.07.001 (2009).
23. Collins, P. HDL-C in post-menopausal women: An important therapeutic target. Int. J. Cardiol. 124, 275-282, doi: 10.1016/j. ijcard.2007.06.009 (2008).
24. Mercuro, G., Deidda, M., Bina, A., Manconi, E. & Rosano, G. M. Gender-specific aspects in primary and secondary prevention of cardiovascular disease. Curr. Pharm. Des. 17, 1082-1089 (2011).
25. Kiechl, S. et al. Body Iron Stores and the Risk of Carotid Atherosclerosis: Prospective Results From the Bruneck Study. Circulation 96, 3300-3307, doi: 10.1161/01.cir.96.10.3300 (1997).
26. Hellings, W. E. et al. Differences between men and women in the composition of atherosclerotic plaque, as an explanation for the lower success rate of carotid endarterectomy in women. Ned. Tijdsch. Geneeskd. 152, 2624-2631 (2008).
27. Wendorff, C. et al. Carotid Plaque Morphology Is Significantly Associated With Sex, Age, and History of Neurological Symptoms. Stroke 46, 3213-3219, doi: 10.1161/strokeaha.115.010558 (2015).
28. Martin-Ventura, J. L. et al. Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: Detoxifying mechanisms and potential therapeutic options. Thromb. Haemost. 108, 435-442, doi: 10.1160/TH12-04-0248 (2012).
29. Satoh, K. et al. Cyclophilin A Mediates Vascular Remodeling by Promoting Inflammation and Vascular Smooth Muscle Cell Proliferation. Circulation 117, 3088-3098, doi: 10.1161/circulationaha.107.756106 (2008).
30. You, S. A. et al. Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol. Genomics 13, 25-30, doi: 10.1152/physiolgenomics.00124.2002 (2003).
31. Lepedda, A. J. et al. A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis 203, 112-118, doi: 10.1016/j.atherosclerosis.2008.07.001 (2009).
32. Li, W., Xu, L. H., Forssell, C., Sullivan, J. L. & Yuan, X. M. Overexpression of transferrin receptor and ferritin related to clinical symptoms and destabilization of human carotid plaques. Exp. Biol. Med. 233, 818-826, doi: 10.3181/0711-RM-320 (2008).
33. Stan, S., Delvin, E., Lambert, M., Seidman, E. & Levy, E. Apo A-IV: An update on regulation and physiologic functions. Biochim. Biophys. Acta 1631, 177-187, doi: 10.1016/S1388-1981(03)00004-0 (2003).
34. Recalde, D. et al. Human Apolipoprotein A-IV Reduces Secretion of Proinflammatory Cytokines and Atherosclerotic Effects of a Chronic Infection Mimicked by Lipopolysaccharide. Arterioscler. Thromb. Vasc. Biol 24, 756-761, doi: 10.1161/01. atv.0000119353.03690.22 (2004).
35. Wong, W.-M. R. et al. Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation. Atherosclerosis 192, 266-274, doi: 10.1016/j.atherosclerosis.2006.07.017 (2007).
36. Yuan, X.-M., Li, W., Baird, S. K., Carlsson, M. & Melefors, Ö. Secretion of Ferritin by Iron-laden Macrophages and Influence of Lipoproteins. Free Radic. Res. 38, 1133-1142, doi: 10.1080/10715760400011692 (2004).
37. Görg, A., Obermaier, C., Boguth, G. & Harder, A. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21, 1037-1053 (2000).
38. Karlsson, H. et al. Wear Particles from Studded Tires and Granite Pavement Induce Pro-inflammatory Alterations in Human Monocyte-Derived Macrophages: A Proteomic Study. Chem. Res. Toxicol 24, 45-53, doi: 10.1021/tx100281f (2011).
39. Karlsson, H., Leanderson, P., Tagesson, C. & Lindahl, M. Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 5, 1431-1445 (2005).
40. Lindahl, M., Stahlbom, B., Svartz, J. & Tagesson, C. Protein patterns of human nasal and bronchoalveolar lavage fluids analyzed with two-dimensional gel electrophoresis. Electrophoresis 19, 3222-3229 (1998).
41. Ghafouri, B., Stahlbom, B., Tagesson, C. & Lindahl, M. Newly identified proteins in human nasal lavage fluid from non-smokers and smokers using two-dimensional gel electrophoresis and peptide mass fingerprinting. Proteomics 2, 112-120 (2002).
42. Vizcaíno, J. A. et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 44, D447-D456, doi: 10.1093/nar/gkv1145 (2016).